BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23881657)

  • 1. Intermittent drug techniques for schizophrenia.
    Sampson S; Mansour M; Maayan N; Soares-Weiser K; Adams CE
    Cochrane Database Syst Rev; 2013 Jul; (7):CD006196. PubMed ID: 23881657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM; Leucht S
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008016. PubMed ID: 32840872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent drug techniques for schizophrenia.
    Sampson S; Joshi K; Mansour M; Adams CE
    Schizophr Bull; 2013 Sep; 39(5):960-1. PubMed ID: 23861538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone (depot) for schizophrenia.
    Sampson S; Hosalli P; Furtado VA; Davis JM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.
    Bergman H; Rathbone J; Agarwal V; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD000459. PubMed ID: 29409162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zuclopenthixol dihydrochloride for schizophrenia.
    Bryan EJ; Purcell MA; Kumar A
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005474. PubMed ID: 29144549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.
    Adelufosi AO; Abayomi O; Ojo TM
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010501. PubMed ID: 25866243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.
    Mahapatra J; Quraishi SN; David A; Sampson S; Adams CE
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001470. PubMed ID: 24915451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.
    Rodolico A; Siafis S; Bighelli I; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014384. PubMed ID: 36420692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimozide for schizophrenia or related psychoses.
    Mothi M; Sampson S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine versus typical neuroleptic medication for schizophrenia.
    Essali A; Al-Haj Haasan N; Li C; Rathbone J
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD000059. PubMed ID: 19160174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trifluoperazine versus placebo for schizophrenia.
    Koch K; Mansi K; Haynes E; Adams CE; Sampson S; Furtado VA
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD010226. PubMed ID: 24414883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil for people with schizophrenia or related disorders.
    Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias QuiƱones GE; Seegers M; Colunga-Lozano LE
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluphenazine decanoate (depot) and enanthate for schizophrenia.
    Maayan N; Quraishi SN; David A; Jayaswal A; Eisenbruch M; Rathbone J; Asher R; Adams CE
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000307. PubMed ID: 25654768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
    Alabed S; Latifeh Y; Mohammad HA; Bergman H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000203. PubMed ID: 29663328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
    Bergman H; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000204. PubMed ID: 29341071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.